Home > Journals > Panminerva Medica > Past Issues > Panminerva Medica 2022 March;64(1) > Panminerva Medica 2022 March;64(1):119-20

CURRENT ISSUE
 

JOURNAL TOOLS

Publishing options
eTOC
To subscribe
Submit an article
Recommend to your librarian
 

ARTICLE TOOLS

Publication history
Reprints
Permissions
Cite this article as
Share

 

LETTERS TO THE EDITOR   

Panminerva Medica 2022 March;64(1):119-20

DOI: 10.23736/S0031-0808.19.03705-4

Copyright © 2019 EDIZIONI MINERVA MEDICA

language: English

LncRNA CYTOR and MIR4435-2HG in ovarian cancer and its relationship with clinicopathological features

Shanjun LIU 1, 2, Zhu QIAO 3, Qi MA 3, Xiaowei LIU 3, Xuezhen MA 4

1 Qingdao University, Qingdao, China; 2 Department of Traditional Chinese Medicine, Affiliated Hospital of Jining Medical University, Jining, China; 3 Department of Oncology, The Affiliated Hospital of Jining Medical University, Jining, China; 4 Department of Oncology, The Second Affiliated Hospital of Medical College Qingdao University, Qingdao, China



top of page